Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Session: New Antimicrobials in the Pipeline Part 1

29 - MAT2203, A Novel Oral Delivery of Amphotericin B (AMB), in Phase 3 Development for the Treatment of Invasive Fungal Infections (Matinas BioPharma)

Thursday, October 12, 2023
8:12 AM – 8:24 AM US ET
Location: 104 ABC
Disclosure(s):
Theresa Matkovits, PhD: Matinas BioPharma Holdings, Inc.: Employee (Ongoing)